Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis

Molecular Therapy

Volumn 5, Issue 5, 2002, Pages 547-554

  Yin, Guoyong ^a   Liu, Weimin ^a   An, Ping ^a   Li, Ping ^a   Ding, Ivan ^a   Planelles, Vicente ^a   Schwarz, Edward M ^a   Min, Wang ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Antiangiogenesis; Chemokine; Endostatin; Gene therapy; Inflammation; JNK; Lentiviral vector; Rheumatoid arthritis; TNF

Indexed keywords

ANGIOGENESIS INHIBITOR; CYTOKINE; ENDOSTATIN; LENTIVIRUS VECTOR; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANNUS; RHEUMATOID ARTHRITIS; SYNOVIUM; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALIA; LENTIVIRUS; MUS MUSCULUS;

EID: 0036106283     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0590     Document Type: Article

References (45)

1. Review: Angiogenesis: Implications for rheumatoid arthritis
2. Angiogenesis and arthritis
3. Rheumatoid arthritis. Pathophysiology and implications for therapy
4. Rheumatoid arthritis
5. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
6. Inhibitory effect of TNF α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
7. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis
8. Anti-TNF α therapy of rheumatoid arthritis: What have we learned?
9. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
10. The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis
11. Type II collagen-induced arthritis
12. Modulation of life and death by the TNF receptor superfamily
13. Tumor necrosis factor-α-induced E-selectin expression is activated by the nuclear factor-κB and c-jun N-terminal kinase/p38 mitogen-activated protein kinase pathways
14. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-κ B and TRAF-RAC/CDC42-JNK-c-jun/ATF2 pathways
15. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis
16. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
17. Cloning, expression, and in vitro activity of human endostatin
18. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
19. Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models
20. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas
21. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
22. Gene therapy-promises, problems and prospects
23. Signal transduction by the JNK group of MAP kinases
24. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes
25. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in rheumatoid arthritis
26. Jun N-terminal kinase in rheumatoid arthritis
27. Role of cytokines in rheumatoid arthritis
28. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
29. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
30. Angiogenesis inhibition suppresses collagen arthritis
31. Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: An ultrastructural demonstration of an increased superficial chondroprotective layer
32. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
33. Antiangiogenic gene therapy
34. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
35. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin
36. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice
37. Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation
38. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
39. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration
40. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis
41. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
42. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
43. Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis
44. Starving the synovium: Angiogenesis and inflammation in rheumatoid arthritis
45. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis